Hangzhou, China

Jianan Li

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jhm Biopharmaceutical (Hangzhou) Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianan Li. Retrieved from https://idiyas.com/inventor/jianan-li-yox9ivsq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jianan Li - Innovator in Biopharmaceuticals

Introduction

Jianan Li is an accomplished inventor based in Hangzhou, China. He is currently associated with JHM Biopharmaceutical (Hangzhou) Co., Ltd. Despite having no granted patents to his name, his work in the field of biopharmaceuticals is noteworthy. Jianan collaborates with talented coworkers, including Guoqing Bao and Liming Guo, contributing to innovative research and development.

Latest Patent Applications

Jianan Li's latest patent application is titled "Growth Hormone Fusion Protein and Preparation Method and Use Thereof." This application describes a growth hormone fusion protein that includes a double-stranded structure with a first and second constant region Fc segment. The growth hormone linked to the first constant region Fc segment has no methionine at its N-terminus. The fusion protein is expressed using a non-mammalian cell expression system. This innovative approach aims to prolong the in vivo half-life of the growth hormone while ensuring that the active site remains unaffected by steric hindrance, thus enhancing its activity and safety.

Conclusion

Jianan Li's contributions to the field of biopharmaceuticals, particularly through his latest patent application, highlight his innovative spirit and dedication to advancing medical science. His work promises to have a significant impact on the development of effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…